{
    "organizations": [],
    "uuid": "6cba78a2237ce9379ae031c60a705feadb3578c0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-irlab-therapeutics-q4-operating-lo/brief-irlab-therapeutics-q4-operating-loss-at-sek-13-million-idUSFWN1QH021",
    "ord_in_thread": 0,
    "title": "BRIEF-Irlab Therapeutics Q4 Operating Loss At SEK 13 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Irlab Therapeutics Ab:\n* PROPOSES NO DIVIDEND FOR 2017 * Q4 OPERATING LOSS AT SEK 13 MILLION VERSUS LOSS SEK 14.6 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-27T14:48:00.000+02:00",
    "crawled": "2018-02-28T12:43:03.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "irlab",
        "therapeutic",
        "ab",
        "proposes",
        "dividend",
        "q4",
        "operating",
        "loss",
        "sek",
        "million",
        "versus",
        "loss",
        "sek",
        "million",
        "year",
        "ago",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}